Trenbolone Hexahydrobenzylcarbonate 76.5 mg Injection
Description
Hexabol 76.5 mg Injection contains Trenbolone Hexahydrobenzylcarbonate, a synthetic anabolic-androgenic steroid.
It is a long-acting ester formulation of trenbolone, an androgen receptor agonist.
Trenbolone compounds have been studied for their anabolic and androgenic properties.
A historical human formulation was marketed under the name Parabolan but was subsequently discontinued.
Hexabol should not be presented as an approved treatment for muscle growth or hormonal disorders without verified regulatory authorisation.
Non-medical use of trenbolone carries significant cardiovascular, hormonal and psychological risks.
Precautions
- Avoid unsupervised human use.
- Anabolic-androgenic steroids may cause cardiovascular complications, including increased blood pressure and adverse cholesterol changes.
- Hormonal suppression, reduced fertility, acne and mood changes may occur.
- Liver and kidney-related complications have been reported with anabolic steroid misuse.
- Injectable products carry additional infection risks if sterility is compromised.
- Avoid use during pregnancy because of potential fetal harm.
- Consult a qualified healthcare professional regarding suspected steroid-related adverse effects.
Uses
Pharmacological and historical information:
- Trenbolone has anabolic and androgenic activity.
- Trenbolone compounds have been used in veterinary contexts to promote growth in livestock.
- Trenbolone Hexahydrobenzylcarbonate was historically marketed for certain human medical purposes in France, but that product was discontinued.
Storage and Handling
- Store according to the manufacturer's verified product label.
- Protect from excessive heat and direct sunlight where specified by the manufacturer.
- Do not freeze unless the product information explicitly permits it.
- Inspect packaging integrity, expiry date and batch details.
- Do not use an injectable product showing unexpected particles, discoloration or signs of contamination.
- Handling and disposal should follow applicable pharmaceutical safety procedures.
Specifications
| Pharmacological Action | Androgen receptor agonist |
|---|

